For research use only
| Cat No. | ABC-TC0533 |
| Product Type | Human Nerve Tumors Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Product Code | KNS 60; KNS60 |
KNS-60 glioma cells from pediatric GBM support brain tumor studies, offering a reliable model for neuro-oncology and therapeutic research.
KNS-60 is a human glioblastoma (grade IV glioma) cell line derived from a brain tumor of a 5‑year‑old female patient. These cells exhibit adherent growth with epithelial-like morphology and can be continuously passaged in vitro. KNS-60 cells are negative for GFAP, S-100, and neuron-specific enolase (NSE), making them valuable for studying glioma biology beyond typical astrocyte markers. Genomic analysis has revealed amplification of the Skp2 gene on chromosome 5p, which correlates with poor prognosis in glioblastoma. Gene expression profiling shows diverse oncogenic and signaling pathway activities, establishing KNS-60 as a robust model for pharmacogenomics and drug response research.
| Product Code | KNS 60; KNS60 |
| Species | Human |
| Cat.No | ABC-TC0533 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Nerve Tumors Cell Lines |
KNS-60 cells are an established model for glioma research, supporting studies on tumor biology, radiation response, and drug screening. Cataloged in pharmacogenomics databases like CellMinerCDB, they provide insights into drug sensitivity and genetic correlations, advancing personalized medicine approaches. Researchers use this line to evaluate new treatments for gliomas and to investigate mechanisms of cancer progression in the brain.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).